College of Osteopathic Medicine, Kansas City University, Kansas City, Missouri.
Mo Med. 2024 Jan-Feb;121(1):87-92.
Optic atrophy 1(OPA1) is a GTPase protein that controls mitochondrial fusion, cristae integrity, and mtDNA maintenance. In neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), the mitochondrial network morphology is compromised. Studies on TAR-DNA binding protein 43 (TDP-43) has been the focus in our lab. OPA1 and TDP-43 interaction may shed a light on how aberrant TDP-43 interacts with OPA1, which will lead to mitochondrial dysfunction. The preliminary study tested the idea of whether OPA1 and TDP-43 are physically interacting in human platelet derived mitochondria obtained from healthy human subjects.
视神经萎缩 1(OPA1)是一种 GTP 酶蛋白,可控制线粒体融合、嵴完整性和 mtDNA 维持。在神经退行性疾病(如阿尔茨海默病(AD)、肌萎缩性侧索硬化症(ALS)、帕金森病(PD)中,线粒体网络形态受到损害。我们实验室的研究重点是 TAR-DNA 结合蛋白 43(TDP-43)。OPA1 和 TDP-43 的相互作用可能揭示异常 TDP-43 与 OPA1 相互作用的方式,这将导致线粒体功能障碍。初步研究测试了 OPA1 和 TDP-43 是否在从健康人类受试者获得的人血小板衍生线粒体中物理相互作用的想法。